Nessan Bermingham - Net Worth and Insider Trading

Nessan Bermingham Net Worth

The estimated net worth of Nessan Bermingham is at least $8 Million dollars as of 2024-11-13. Nessan Bermingham is the President & CEO of Intellia Therapeutics Inc and owns about 458,250 shares of Intellia Therapeutics Inc (NTLA) stock worth over $8 Million. Details can be seen in Nessan Bermingham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nessan Bermingham has not made any transactions after 2017-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nessan Bermingham

To

Nessan Bermingham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nessan Bermingham owns 3 companies in total, including Intellia Therapeutics Inc (NTLA) , F-star Therapeutics Inc (FSTX) , and Korro Bio Inc (KRRO) .

Click here to see the complete history of Nessan Bermingham’s form 4 insider trades.

Insider Ownership Summary of Nessan Bermingham

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2017-12-08 director & 10 percent owner & President & CEO
FSTX F-star Therapeutics Inc 2023-03-08 director
KRRO Korro Bio Inc 2023-11-03 director

Nessan Bermingham Latest Holdings Summary

Nessan Bermingham currently owns a total of 1 stock. Nessan Bermingham owns 458,250 shares of Intellia Therapeutics Inc (NTLA) as of December 8, 2017, with a value of $8 Million.

Latest Holdings of Nessan Bermingham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NTLA Intellia Therapeutics Inc 2017-12-08 458,250 16.65 7,629,863

Holding Weightings of Nessan Bermingham


Nessan Bermingham Form 4 Trading Tracker

According to the SEC Form 4 filings, Nessan Bermingham has made a total of 0 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years. The most-recent trade in Intellia Therapeutics Inc is the sale of 336,783 shares on December 8, 2017, which brought Nessan Bermingham around $7 Million.

Insider Trading History of Nessan Bermingham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nessan Bermingham Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nessan Bermingham Ownership Network

Ownership Network List of Nessan Bermingham

No Data

Ownership Network Relation of Nessan Bermingham

Insider Network Chart

Nessan Bermingham Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Nessan Bermingham is the director & 10 percent owner & President & CEO of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Nessan Bermingham made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .

In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

Nessan Bermingham Mailing Address

Above is the net worth, insider trading, and ownership report for Nessan Bermingham. You might contact Nessan Bermingham via mailing address: 890 Winter Street, Waltham Ma 02451.